At a glance
ClinicalIndex Comparison Record- ✓Age older than 17 at screening
- ✓Healthy per investigator assessment
- ✓At least two keloids of comparable size and texture on same general anatomic location (trunk or back)
- ✓Willing to comply with protocol visits and 4-week washout period
- ✕Pregnancy or breastfeeding, or planning pregnancy during study
- ✕History of coagulopathy
- ✕Current anticoagulant or antiplatelet therapy
- ✕Known allergy or sensitivity to local anesthetics (EMLA, tetracaine 7%/lidocaine 23%) or local antiseptics planned for laser
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids
In Brief
A clinical study evaluating The Lutronic electronic carbon dioxide (eCO2) Plus laser system and Intralesional Triamcinolone Acetonide for Keloid. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the effects of fractional carbon dioxide (CO2) laser therapy immediately followed by intralesional steroid therapy against intralesional steroid therapy alone for the treatment of keloids.
Study Details
Timeline
Interventions
CO2 ablative laser plus intralesional triamcinolone acetonide A topical EMLA cream or tetracaine 7%/lidocaine 23% will be applied to the both treatment sites and after sufficient anesthesia is attained, one keloid will be treated with the fractional CO2 laser using standard protocol as practiced in our clinics followed by intralesional triamcinolone acetonide. One lesion would be treated with fractional CO2 ablative laser followed with intralesional triamcinolone acetonide at 4 weeks intervals